KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Depreciation and Depletion: 2020-2024

Historic Depreciation and Depletion for Aurinia Pharmaceuticals (AUPH) over the last 4 years, with Dec 2024 value amounting to -$14.0 million.

  • Aurinia Pharmaceuticals' Depreciation and Depletion fell 129.30% to -$14.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $600,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $600,000 for FY2024, which is negligibly% changed negligibly from last year.
  • Per Aurinia Pharmaceuticals' latest filing, its Depreciation and Depletion stood at -$14.0 million for Q4 2024, which was down 385.78% from $4.9 million recorded in Q3 2024.
  • In the past 5 years, Aurinia Pharmaceuticals' Depreciation and Depletion registered a high of $5.3 million during Q3 2023, and its lowest value of -$14.0 million during Q4 2024.
  • In the last 3 years, Aurinia Pharmaceuticals' Depreciation and Depletion had a median value of $718,000 in 2023 and averaged $150,000.
  • Within the past 5 years, the most significant YoY rise in Aurinia Pharmaceuticals' Depreciation and Depletion was 5,633.33% (2021), while the steepest drop was 7,494.44% (2021).
  • Aurinia Pharmaceuticals' Depreciation and Depletion (Quarterly) stood at -$18,000 in 2020, then plummeted by 7,494.44% to -$1.4 million in 2021, then crashed by 38.04% to -$1.9 million in 2022, then plummeted by 223.16% to -$6.1 million in 2023, then crashed by 129.30% to -$14.0 million in 2024.
  • Its Depreciation and Depletion was -$14.0 million in Q4 2024, compared to $4.9 million in Q3 2024 and $4.8 million in Q2 2024.